Showing results (2901-2910 of 8,043) with videos related to
Sort By:
Pageof 805
Current Medicinal Chemistry|January 29, 2008
The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugsSeoung-Ryoung Choi, Prasenjit Mukherjee, Mitchell A AveryCurrent Medicinal Chemistry|February 28, 2002
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphinePal Riba, Yong Ben, Thi M-D Nguyen, et al.Current Medicinal Chemistry|February 28, 2002
New trends in the development of oral antidiabetic drugsValeria Kecskemeti, Zsolt Bagi, Pal Pacher, et al.Current Medicinal Chemistry|February 28, 2002
Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumoursJ F W Nijsen, A D van het Schip, W E Hennink, et al.Current Medicinal Chemistry|February 28, 2002
Progress towards the discovery of xanthine oxidase inhibitorsF Borges, E Fernandes, F RoleiraCurrent Medicinal Chemistry|February 28, 2002
Polycarboxylate fluorescent indicators as ion concentration probes in biological systemsH E Katerinopoulos, E FoukarakiCurrent Medicinal Chemistry|February 28, 2002
DNA-binding of drugs used in medicinal therapiesG Bischoff, S HoffmannCurrent Medicinal Chemistry|November 30, 2007
Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitorsAntonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava, et al.Current Medicinal Chemistry|November 30, 2007
Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a reviewM F Reynolds, E C Sisk, N L RasgonCurrent Medicinal Chemistry|November 30, 2007
Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's diseaseS Bandyopadhyay, L E Goldstein, D K Lahiri, et al.Pageof 805